Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Potenza Therapeutics’ pipeline of oncology products utilizes the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. In April 2015, Potenza and Astellas announced an exclusive collaboration to develop novel antibodies for immuno-oncology therapy. Drug discovery activities are conducted by the drug discovery scientists at Potenza, in close colla...
Potenza Therapeutics’ pipeline of oncology products utilizes the body’s own immune system to seek out, recognize and destroy tumors through a diversity of mechanisms that influence tumor immunity. In April 2015, Potenza and Astellas announced an exclusive collaboration to develop novel antibodies for immuno-oncology therapy. Drug discovery activities are conducted by the drug discovery scientists at Potenza, in close collaboration with Astellas. Once a drug is ready for human clinical use, the global reach of Astellas enables advancement of clinical development activities and commercialization.

List your booth number for exhibitions, ask us